Shyamakant Giri has been appointed as the new CEO of Gland Pharma, effective January 15, 2025. Giri brings over 25 years of experience in the pharmaceutical and healthcare sectors. The current CEO, Srinivas Sadu, will remain as the executive chairman to support the company's growth trajectory.
